XML 135 R115.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 19 - Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2018
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)         500,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)   151,000        
Proceeds (Used for) and Received from Settlement of Stock Awards   $ 175,000 $ 233,000      
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   106,000        
Share-based Compensation Arrangement by Share-based Payment Award, Expected Shares to be Awarded (in shares)   111,000        
Stock Appreciation Rights (SARs) [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) [1]   151,000        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)   10 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)   29,000 34,000 30,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number (in shares)   440,000        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Exercise Price (in dollars per share)   $ 38.11        
Stock Appreciation Rights (SARs) [Member] | Minimum [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Exercise Price (in dollars per share)   19.44 $ 19.37 $ 15.24   $ 15.24
Stock Appreciation Rights (SARs) [Member] | Maximum [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Exercise Price (in dollars per share)   $ 74.92 $ 74.92 $ 50.71   $ 40
Stock Appreciation Rights (SARs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage   20.00%        
Restricted Stock [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   5 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)   38,000 35,000 39,000    
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   98,000        
Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   3 years        
Sharebased Compensation Arrangement by Share-based Payment Award Post Vesting Holding Period (Year)   1 year        
Share-based Compensation Arrangement by Share-based Payment Award Liquidity Discount   5.20% 5.80% 6.10%    
Performance Shares [Member] | Minimum [Member]            
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   0        
Performance Shares [Member] | Maximum [Member]            
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   166,000        
Restricted Stock Units (RSUs) [Member]            
Common Stock, Capital Shares Reserved for Future Issuance (in shares)   8,000        
Restricted Stock Units (RSUs) [Member] | Director [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)   12 months        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 5,410 8,668        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Fair Value Granted $ 350,000 $ 550,000        
[1] Under the 2015 Omnibus Equity Compensation Plan, shares of stock are authorized for issuance as incentive and non-qualified stock options, SARs, RSAs, and RSUs.